Phytoestrogens mediated anti-inflammatory effect through suppression of IRF-1 and pSTAT1 expressions in lipopolysaccharide-activated microglia

International Immunopharmacology

Volumn 17, Issue 2, 2013, Pages 483-488

  Jantaratnotai, Nattinee ^a   Utaisincharoen, Pongsak ^a   Sanvarinda, Pimtip ^a   Thampithak, Anusorn ^b   Sanvarinda, Yupin ^a  

^a Mahidol University   (Thailand)

^b BURAPHA UNIVERSITY   (Thailand)

Author keywords

Cytokines; Microglia; Neuroinflammation; Nitric oxide; Phytoestrogens

Indexed keywords

CHEMOKINE; COUMESTROL; CYTOKINE; DAIDZEIN; ESTRADIOL; GENISTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERFERON REGULATORY FACTOR 1; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; PHYTOESTROGEN; STAT1 PROTEIN;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ACTIVATION; CELL LINE; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DRUG EFFECT; MEDIATOR; MICROGLIA; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; RECEPTOR DOWN REGULATION;

CYTOKINES; MICROGLIA; NEUROINFLAMMATION; NITRIC OXIDE; PHYTOESTROGENS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE, TRANSFORMED; CHEMOKINE CCL2; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; INTERFERON REGULATORY FACTOR-1; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MICROGLIA; NEURODEGENERATIVE DISEASES; NEUROPROTECTIVE AGENTS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PHYTOESTROGENS; RATS; SOYBEANS; STAT1 TRANSCRIPTION FACTOR;

EID: 84885359067     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2013.07.013     Document Type: Article

References (42)

1. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, et al. Inflammation and Alzheimer's disease. Neurobiol Aging 2000;21:383-421. (Pubitemid 30349107)
2. Hunot S, Hirsch EC. Neuroinflammatory processes in Parkinson's disease. Ann Neurol 2003;53(Suppl. 3):S49-58 [discussion S-60.].
3. Bradl M, Hohlfeld R. Molecular pathogenesis of neuroinflammation. J Neurol Neurosurg Psychiatry 2003;74:1364-70.
4. Gartner S, Liu Y. Insights into the role of immune activation inHIV neuropathogenesis. J Neurovirol 2002;8:69-75. (Pubitemid 34520888)
5. Shah IM, Macrae IM, Di Napoli M.Neuroinflammation and neuroprotective strategies in acute ischaemic stroke - from bench to bedside. Curr Mol Med 2009;9:336-54.
6. Block ML, Hong JS. Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog Neurobiol 2005;76:77-98. (Pubitemid 41242883)
7. Minagar A, Shapshak P, Fujimura R, Ownby R, Heyes M, Eisdorfer C. The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis. J Neurol Sci 2002;202:13-23. (Pubitemid 36153117)
8. Gebicke-Haerter PJ. Microglia in neurodegeneration: molecular aspects. Microsc Res Tech 2001;54:47-58. (Pubitemid 32537334)
9. Skaper SD. The brain as a target for inflammatory processes and neuroprotective strategies. Ann N Y Acad Sci 2007;1122:23-34. (Pubitemid 350249539)
10. Dou H, Kingsley JD, Mosley RL, Gelbard HA, Gendelman HE. Neuroprotective strategies for HIV-1 associated dementia. Neurotox Res 2004;6:503-21.
11. Gao HM, Liu B, Zhang W, Hong JS. Novel anti-inflammatory therapy for Parkinson's disease. Trends Pharmacol Sci 2003;24:395-401. (Pubitemid 36952555)
12. Katzman R, Aronson M, Fuld P, Kawas C, Brown T,Morgenstern H, et al. Development of dementing illnesses in an 80-year-old volunteer cohort. Ann Neurol 1989;25: 317-24. (Pubitemid 19104162)
13. Molsa PK, Marttila RJ, Rinne UK. Epidemiology of dementia in a Finnish population. Acta Neurol Scand 1982;65:541-52. (Pubitemid 12085595)
14. Henderson VW. The epidemiology of estrogen replacement therapy and Alzheimer's disease. Neurology 1997;48:S27-35. (Pubitemid 27230090)
15. Singh M, Sumien N, Kyser C, Simpkins JW. Estrogens and progesterone as neuroprotectants: what animal models teach us. Front Biosci 2008;13:1083-9. (Pubitemid 351594750)
16. Raz L, Khan MM, Mahesh VB, Vadlamudi RK, Brann DW. Rapid estrogen signaling in the brain. Neurosignals 2008;16:140-53. (Pubitemid 351263221)
17. Pozzi S, Benedusi V,Maggi A, Vegeto E. Estrogen action in neuroprotection and brain inflammation. Ann N Y Acad Sci 2006;1089:302-23. (Pubitemid 47092090)
18. Vegeto E, Benedusi V, Maggi A. Estrogen anti-inflammatory activity in brain: a therapeutic opportunity for menopause and neurodegenerative diseases. Front Neuroendocrinol 2008;29:507-19.
19. Wassertheil-Smoller S, Hendrix SL, LimacherM, Heiss G, Kooperberg C, Baird A, et al. Effect of estrogen plus progestin on stroke in postmenopausalwomen: theWomen's Health Initiative: a randomized trial. JAMA 2003;289:2673-84. (Pubitemid 37430138)
20. Mastorakos G, Sakkas EG, Xydakis AM, Creatsas G. Pitfalls of the WHIs: Women's Health Initiative. Ann N Y Acad Sci 2006;1092:331-40. (Pubitemid 47092350)
21. Klaiber EL, Vogel W, Rako S. A critique of the Women's Health Initiative hormone therapy study. Fertil Steril 2005;84:1589-601. (Pubitemid 41785650)
22. Dixon RA. Phytoestrogens. Annu Rev Plant Biol 2004;55:225-61. (Pubitemid 38940932)
23. Kurzer MS, Xu X. Dietary phytoestrogens. Annu Rev Nutr 1997;17:353-81. (Pubitemid 27328805)
24. Lephart ED, West TW, Weber KS, Rhees RW, Setchell KD, Adlercreutz H, et al. Neurobehavioral effects of dietary soy phytoestrogens. Neurotoxicol Teratol 2002;24:5-16. (Pubitemid 34143245)
25. Trieu VN, Uckun FM. Genistein is neuroprotective in murine models of familial amyotrophic lateral sclerosis and stroke. Biochem Biophys Res Commun 1999;258: 685-8. (Pubitemid 29290330)
26. Wang X, Chen S, Ma G, Ye M, Lu G. Genistein protects dopaminergic neurons by inhibiting microglial activation. Neuroreport 2005;16:267-70. (Pubitemid 40364588)
27. Marotta F,Mao GS, Liu T, Chui DH, Lorenzetti A, Xiao Y, et al. Anti-inflammatory and neuroprotective effect of a phytoestrogen compound on rat microglia. Ann N Y Acad Sci 2006;1089:276-81. (Pubitemid 47092088)
28. Chen HQ, Wang XJ, Jin ZY, Xu XM, Zhao JW, Xie ZJ. Protective effect of isoflavones from Trifolium pratense on dopaminergic neurons. Neurosci Res 2008;62:123-30.
29. Jantaratnotai N, Utaisincharoen P, Piyachaturawat P, Chongthammakun S, Sanvarinda Y. Inhibitory effect of Curcuma comosa on NO production and cytokine expression in LPS-activated microglia. Life Sci 2006;78:571-7. (Pubitemid 41785762)
30. Samardzic T, Jankovic V, Stosic-Grujicic S, Trajkovic V. STAT1 is required for iNOS activation, but not IL-6 production in murine fibroblasts. Cytokine 2001;13:179-82. (Pubitemid 32579308)
31. Merrill JE, Ignarro LJ, Sherman MP, Melinek J, Lane TE. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol 1993;151:2132-41. (Pubitemid 23235686)
32. Chao CC, Hu S, Molitor TW, Shaskan EG, Peterson PK. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J Immunol 1992;149: 2736-41.
33. Middleton Jr E, Kandaswami C, Theoharides TC. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 2000;52:673-751.
34. Yen GC, Lai HH. Inhibitory effects of isoflavones on nitric oxide- or peroxynitritemediated DNA damage in RAW 264.7 cells and phiX174 DNA. Food Chem Toxicol 2002;40:1433-40.
35. Watanabe S, Yamaguchi M, Sobue T, Takahashi T, Miura T, Arai Y, et al. Pharmacokinetics of soybean isoflavones in plasma, urine and feces of men after ingestion of 60 g baked soybean powder (kinako). J Nutr 1998;128: 1710-5. (Pubitemid 28452856)
36. Linford NJ, Yang Y, Cook DG, Dorsa DM. Neuronal apoptosis resulting from high doses of the isoflavone genistein: role for calcium and p42/44 mitogen-activated protein kinase. J Pharmacol Exp Ther 2001;299:67-75. (Pubitemid 32905119)
37. Kamijo R, Harada H, Matsuyama T, Bosland M, Gerecitano J, Shapiro D, et al. Requirement for transcription factor IRF-1 in NO synthase induction inmacrophages. Science 1994;263:1612-5. (Pubitemid 24128365)
38. Gao JJ, Filla MB, Fultz MJ, Vogel SN, Russell SW, Murphy WJ. Autocrine/paracrine IFN-alphabeta mediates the lipopolysaccharide-induced activation of transcription factor Stat1alpha in mouse macrophages: pivotal role of Stat1alpha in induction of the inducible nitric oxide synthase gene. J Immunol 1998;161:4803-10. (Pubitemid 28492057)
39. Qiu Z, Sweeney DD, Netzeband JG, Gruol DL. Chronic interleukin-6 alters NMDA receptor-mediated membrane responses and enhances neurotoxicity in developing CNS neurons. J Neurosci 1998;18:10445-56. (Pubitemid 29016564)
40. Galasso JM, Liu Y, Szaflarski J, Warren JS, Silverstein FS. Monocyte chemoattractant protein-1 is a mediator of acute excitotoxic injury in neonatal rat brain.Neuroscience 2000;101:737-44.
41. Hsieh YC, Frink M, Hsieh CH, Choudhry MA, Schwacha MG, Bland KI, et al. Downregulation of migration inhibitory factor is critical for estrogen-mediated attenuation of lung tissue damage following trauma-hemorrhage. Am J Physiol Lung Cell Mol Physiol 2007;292:L1227-32. (Pubitemid 47084867)
42. Yada-Hashimoto N, Nishio Y, Ohmichi M, Hayakawa J, Mabuchi S, Hisamoto K, et al. Estrogen and raloxifene inhibit the monocytic chemoattractant protein-1-induced migration of human monocytic cells via nongenomic estrogen receptor alpha. Menopause 2006;13:935-41. (Pubitemid 44760386)